Scientist - Infectious Diseases - Oxford Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transformative medicines which address unmet patient needs
Assistant Director (Senior Manager), Operational Due Diligence, Strategy & Execution, EY-Parthenon All potential candidates should read through the following details of this job with care before making an application. At EY, we’re all in to shape
Assistant Director (Senior Manager) – Procurement - Operational Strategy - Strategy and Execution - EY-Parthenon Ready to apply Before you do, make sure to read all the details pertaining to this job in the description below.
At EY, we’re all in to shape your future with confidence. Read on to find out what you will need to succeed in this position, including skills, qualifications, and experience. We’ll help you succeed in a
Senior Executive (Manager), Deal Management, Strategy and Execution – EY Parthenon Not sure what skills you will need for this opportunity Simply read the full description below to get a complete picture of candidate requirements. At
Senior Manager - International Tax & Transaction Services - Real Estate, Hospitality & Construction Ensure all your application information is up to date and in order before applying for this opportunity. We’ve got an exciting opportunity
At EY, we’re all in to shape your future with confidence. A variety of soft skills and experience may be required for the following role Please ensure you check the overview below carefully. We’ll help you
At EY, we’re all in to shape your future with confidence. Not sure what skills you will need for this opportunity Simply read the full description below to get a complete picture of candidate requirements. We’ll
Senior Executive (Manager) - Procurement, Operational Strategy, Strategy and Execution, EY-Parthenon Find out more about the daily tasks, overall responsibilities, and required experience for this opportunity by scrolling down now. At EY, we’re all in to